KOL Conversation: New & Emerging Treatment Considerations for PBC & PBC Pruritus

In this episode, Jordan Mayberry, PA-C from UT Southwestern Medical Center, discusses how newly approved therapies are transforming the management of cholestatic pruritus in Primary Biliary Cholangitis (PBC). With pruritus being one of the most challenging symptoms for PBC patients, these emerging treatments offer a targeted approach to improving patient quality of life.

As PBC patients often struggle with persistent itching that significantly impacts daily activities, the availability of FDA-approved therapies specifically addressing PBC-related pruritus represents a major advancement. Jordan Mayberry emphasizes the importance of screening for PBC in patients experiencing chronic pruritus, as early diagnosis and treatment can lead to better disease management and improved symptom control.

With more therapeutic options available, providers can now offer a comprehensive treatment plan that not only targets disease progression but also alleviates pruritus, a symptom that has long been difficult to manage. Watch now to learn more about these groundbreaking therapies and how they are reshaping PBC treatment strategies. For additional resources, visit the GHAPP website or download the GHAPP ACE mobile app.